Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The complement system in ischemic heart disease.

M Yasuda1, K Takeuchi, M Hiruma

  • 1First Department of Internal Medicine, Osaka City University Medical School, Japan.

Circulation
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery and functional characterization of a novel small molecule inhibitor of the intracellular phosphatase, SHIP2.

British journal of pharmacology·2009
Same author

Effects of antidiabetic drugs on glucose tolerance in streptozotocin-nicotinamide-induced mildly diabetic and streptozotocin-induced severely diabetic mice.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2008
Same author

The natural history of carpal tunnel syndrome. A study of 20 hands evaluated 4 to 9 years after initial diagnosis.

Electromyography and clinical neurophysiology·2003
Same author

Efficacy and safety of PTCA using brachial approach and low-dose heparin.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2001
Same author

Effects of YM471, a nonpeptide AVP V(1A) and V(2) receptor antagonist, on human AVP receptor subtypes expressed in CHO cells and oxytocin receptors in human uterine smooth muscle cells.

British journal of pharmacology·2001
Same author

Influence of colonization with mutans streptococci on caries risk in Japanese preschool children: 24 month survival analysis.

Pediatric dentistry·2000
Same journal

Eugene Braunwald, MD, 1929-2026.

Circulation·2026
Same journal

AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026).

Circulation·2026
Same journal

Advancing Quality in the Evaluation, Surveillance, and Management of Aortic Stenosis: A Report From the AHA Target: AS Registry.

Circulation·2026
Same journal

Heart Failure Occurring in the Perinatal Period: A Scientific Statement From the American Heart Association.

Circulation·2026
Same journal

Correction to: 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Circulation·2026
Same journal

Correction to: The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry Analysis.

Circulation·2026
See all related articles

Complement system activation occurs in acute myocardial infarction (AMI) and is linked to heart damage. Mild activation is seen in unstable angina, but not stable angina, without cardiac dysfunction.

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Biochemistry

Background:

  • Tissue injury mechanisms post-acute myocardial infarction (AMI) remain unclear.
  • Experimental models suggest complement system involvement in AMI-related microvascular and macrovascular injury.
  • The role of complement activation in angina pectoris is not well-defined.

Purpose of the Study:

  • To investigate the role of the complement system as a mediator of myocardial inflammation.
  • To quantify complement activation products in patients with AMI, unstable angina, stable angina, and healthy volunteers.
  • To assess the association between complement activation and myocardial damage.

Main Methods:

  • Quantification of complement activation products (C3d, C4d, Bb, SC5b-9) in plasma samples.

Related Experiment Videos

  • Study included 31 AMI patients, 17 unstable angina patients, 19 stable angina patients, and 20 normal volunteers.
  • Correlations between SC5b-9 levels and peak creatine phosphokinase, ejection fraction, and heart failure status were analyzed.

    • Main Results:

    • Plasma C3d levels were elevated in AMI and unstable angina patients (p<0.01).
    • Plasma levels of C4d, Bb, and SC5b-9 were increased exclusively in AMI patients (p<0.01).
    • Plasma SC5b-9 levels correlated with creatine phosphokinase (r=0.71) and inversely with ejection fraction (r=-0.71), and were higher in AMI patients with heart failure.

    Conclusions:

    • Complement system activation is evident following AMI and associated with myocardial damage.
    • Mild complement system activation occurs in unstable angina pectoris without cardiac functional impairment.
    • The complement system is not activated in stable angina pectoris.